Active ingredientMetolazoneCat. No. P-M107-001CAS 17560-51-9Family · Pharmaceutical analytical standards
Metolazone
A thiazide-like diuretic with a quinazoline structure, patented in 1966 and approved in 1974 for heart failure, high blood pressure and oedema; it is often added to loop diuretics. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It is not a true thiazide, because it lacks the benzothiadiazine ring. It was developed by chemist Bola Vithal Shetty, who later helped the FDA review drug applications.
Go to the active ingredient →Active ingredientMetolazoneCat. No. P-M107-001CAS 17560-51-9
Pharmacopoeial impurityMetolazone EP Impurity ACat. No. P-M107-002CAS 50869-25-5
Pharmacopoeial impurityMetolazone EP Impurity BCat. No. P-M107-003CAS 28508-63-6
Pharmacopoeial impurityMetolazone EP Impurity CCat. No. P-M107-004CAS 28524-40-5
Pharmacopoeial impurityMetolazone EP Impurity DCat. No. P-M107-005CAS 4015-23-0
Pharmacopoeial impurityMetolazone EP Impurity ECat. No. P-M107-006CAS 23380-54-3
Isotopically labelledMetolazone-d7Cat. No. P-M107-007CAS 2714484-71-4
NitrosamineN-Nitroso Metolazone Impurity 1Cat. No. P-M107-008
NitrosamineN-Nitroso Metolazone Impurity 2Cat. No. P-M107-010
ImpurityMetolazone Impurity 1Cat. No. P-M107-011
ImpurityMetolazone Impurity 2Cat. No. P-M107-012
ImpurityMetolazone Impurity 3 (Mixture of Enantiomers)Cat. No. P-M107-013No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.